Lv4
501 积分 2021-03-08 加入
From Efficiency to Yield: Exploring Recent Advances in CHO Cell Line Development for Monoclonal Antibodies
1个月前
已完结
Biopharmaceutical Manufacturing, Volume 2
2个月前
已完结
Biopharmaceutical Manufacturing, Volume 2
2个月前
已关闭
Taking the individual bias out of examining comparability of biosimilars: A case study on monoclonal antibody therapeutics
10个月前
已完结
From Efficiency to Yield: Exploring Recent Advances in CHO Cell Line Development for Monoclonal Antibodies
10个月前
已完结
The antibody–drug conjugate landscape
11个月前
已完结
Risk-Based Approach to Setting Sterile Filtration Microbial Bioburden Limits – Focus on Biotech-derived Products
1年前
已完结
Non-specificity as the sticky problem in therapeutic antibody development
1年前
已完结
In-use stability studies: guidelines and challenges
1年前
已完结
皖公网安备34019202002308
